Thursday

30th Jun 2022

Pressure builds on EU to back WTO vaccine-patent waiver

  • Approximately 1.7 billion vaccine doses have been administered worldwide - of which 28 percent went to G7 countries but just 0.3 percent to low-income countries (Photo: imf.org)

MEPs have backed a motion demanding the temporary lifting of intellectual properties rights for Covid-19 vaccines - a symbolic move that puts pressure on the European Commission to change its position on the issue of global access to vaccines.

EU lawmakers adopted the resolution on Wednesday (9 June) with 355 in favour, 263 against, and 71 abstentions - with the results published Thursday.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

The proposal, backing the temporary waiver of patent rules of Covid-19 vaccines, reached a majority thanks to the support of the Socialists and Democrats, the Greens/EFA, The Left and a group of liberal MEPs.

Notably, the centre-right European People's Party voted against it.

India and South Africa, supported by a large group of developing countries and international organisations, demanded in October 2020 a temporary waiver of intellectual property rights for the vaccines and treatments.

In May, the administration of US president Joe Biden also decided to support the initiative.

EU lawmakers adopted an amendment put forward by the Greens in favour of a "proactive, constructive and text-based negotiations for a temporary waiver of the WTO [World Trade Organization] TRIPS Agreement, aiming to enhance global access to affordable Covid-19-related medical products and to address global production constraints and supply shortages".

"We can only tackle this pandemic together and this [vote] is a huge step for ensuring that vaccines are globally accessible," said Green MEP Anna Cavazinni.

For his part, left-wing MEP Martin Schirdewan noted that six months ago this kind of formal support to a patent-waiver would have been "unthinkable".

The TRIPS agreement sets out international rules governing patents, binding for all the 164 countries in the WTO. Any change would require unanimity.

As of June, approximately 1.7 billion vaccine doses have been administered worldwide, of which 28 percent went to G7 countries and 0.3 percent to low-income countries.

EU opposition

The EU Parliament's resolution counters the plan that the commission submitted to the WTO last week - dubbed as "the third way" and based on existing flexibilities within the TRIPS agreement.

The EU executive said on Thursday that it had taken note of the position of MEPs, and it is currently analysing it.

While the EU says it is open to discussing the proposal, the 27-nation bloc, home for many big pharmaceutical firms, is not convinced that this would provide "the best immediate response" to improve global access to vaccines.

In their resolution, EU lawmakers also acknowledged that voluntary licensing (when vaccine-makers and developers enter a licensing and manufacturing partnership with producers in developing countries to expand production), know-how and technology transfer to less developing countries are "the most important way" to scale up global supplies in the long term.

Overall, there are more than 280 partnerships already identified, including with manufacturers in a number of developing countries such as India and South Africa, the commission said.

The EU and its member states pledged to spend €1bn to increase manufacturing capacity in Africa.

Meanwhile, MEPs pointed out that both the US and the UK should "immediately abolish their export ban on vaccines and raw materials required of the production of vaccines" - a call previously made by the EU Commission and Council.

Until now, the EU has exported more than 245 million vaccines to 46 different countries - accounting for about half of the total amount of vaccines produced in Europe. It has also pledged to donate 100 million doses to low and middle-income countries by the end of the year.

By contrast, the US has produced more than 333 million doses of vaccines and exported about three million doses, according to the London-based research firm Airfinity.

All eyes on July's meeting

In a breakthrough in efforts to ease patent rules temporarily, WTO members agreed on Wednesday to move to a text-based negotiation process on the existing patent-waiver proposals - in a bid to reach a consensus for the next meeting.

"Time will show how this will develop," the chair of the TRIPS Council in the WTO, Dagfinn Sørli told EUobserver.

The next meeting is scheduled for 21-22 July. However, some analysts predict that the discussion might last for months.

It is estimated that 11 billion doses are needed, in order to immunise 70 percent of the world's population.

Over the weekend, G7 countries will discuss ways to increase vaccine production worldwide at their summit in Cornwall, UK.

EU counters Biden's vaccine patent-waiver with WTO plan

The EU has submitted to the World Trade Organization a plan aimed at expanding the production of Covid-19 vaccines - seen by Brussels as a quicker and more targeted solution than the intellectual property right-waiver proposal backed by the US.

'Shocking' disparities bolster vaccine patent-waiver call

The unbalanced distribution of vaccines globally has triggered calls to waive intellectual property rights for Covid-19 vaccines. But an analysis of lobbying by watchdog Corporate Europe Observatory revealed how Big Pharma has influenced the EU Commission's position.

Von der Leyen doubles up on vaccine-donation pledge

European Commission president Ursula von der Leyen praised the EU's vaccination roll-out as a success and announced that the EUn will donate 200 million additional doses to low-income countries - doubling its current pledge.

Vaccine-waiver row refuses to die at EU-AU summit

The stark gap in Covid-19 vaccination rates between Europe and Africa is likely to feed into the EU-AU summit negotiations. But a patent waiver still looks like a no-go for Europe.

Opinion

How industry watered-down new EU supply chain rules

The Commission fell hook, line, and sinker for the arguments of big business on the corporate due diligence directive — conflating rules and regulations with so-called 'red tape' and rebranding regulations as 'burdens' on business which should be scrapped.

Podcast

Against white feminism: European edition

Author Rafia Zakaria turned the feminist world upside down with her bestselling book Against White Feminism. She talks with the Brussels-based journalist Shada Islam about the prevalence of white feminist thinking in Europe — particularly France.

News in Brief

  1. New president for European Committee of the Regions
  2. Gas flows from Spain to Morocco, after Western Sahara row
  3. BioNTech, Pfizer test 'universal' coronavirus vaccine
  4. UK sanctions second-richest Russian businessman
  5. Hungary permits emergency supervision of energy firms
  6. Bulgaria expels 70 alleged Russian spies
  7. EU Commission told to improve CAP data analytics
  8. Scotland pushes for second independence vote in 2023

Stakeholders' Highlights

  1. Nordic Council of MinistersEmerging journalists from the Nordics and Canada report the facts of the climate crisis
  2. Council of the EUEU: new rules on corporate sustainability reporting
  3. Nordic Council of MinistersNordic ministers for culture: Protect Ukraine’s cultural heritage!
  4. Reuters InstituteDigital News Report 2022
  5. EFBWW – EFBH – FETBBHow price increases affect construction workers
  6. Nordic Council of MinistersNew Nordic think tank examines influence of tech giants

Latest News

  1. Nato expands and reinforces on Russian flank
  2. EU Commission says it cannot find messages with Pfizer CEO
  3. EU ministers sign off on climate laws amid German infighting
  4. EU presidency still looking for asylum relocation pledges
  5. Finland and Sweden to join Nato, as Erdoğan drops veto
  6. The euro — who's next?
  7. One rubicon after another
  8. Green crime-fighting boss urgently required, key MEP says

Join EUobserver

Support quality EU news

Join us